GSK’s Withdrawn Blood Cancer Drug Paves Path Back to Market
GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...
GSK hails progress for withdrawn blood cancer drug
UK pharma group posts ‘statistically significant’ trial results for treatment combined with Blenrep pulled in 2022 ...
Buy33m
GSK hails survival results in blood cancer patients with Blenrep
(Alliance News) - GSK PLC on Thursday said its Blenrep drug has shown overall survival benefits in patients with relapsed or refractory multiple myeloma, the third most common type of blood cancer.
GSK Blenrep shows strong survival benefit in myeloma study
GSK reported positive results from its phase three ‘DREAMM-7’ trial on Thursday, highlighting a significant overall survival ...
£10 a day invested in UK shares could one day create a second income of over £3,000 a month!
Mark David Hartley outlines a strategy he’d use to aim for a second income that gets bigger over time, by investing just £10 a day. The post £10 a day invested in UK shares could one day create a ...